Clinical implications of new findings in HIV basic research.

HIV Therapy
Manish Sagar

Abstract

HIV has been studied extensively over the past 25 years. Insights into the different stages of the virus' replication cycle and its interaction with host-cell proteins have led to the development of an armamentarium of effective antiretroviral medications. These antiviral drugs have dramatically changed the prognosis for HIV-infected subjects from an inevitable march towards death to a chronic disease with a potentially normal lifespan. Even with these successes, there is a continuing need to provide new drugs, especially those effective against drug-resistant viruses, to devise optimal strategies to prevent adverse events from either immunosuppression or the antiretroviral medications, and to develop treatments aimed at eliminating virus replication in the absence of antiviral drugs. In this review, how these important issues are being addressed will be highlighted, emphasizing clinical implications from some recent basic science studies and demonstrating how they could change the face of HIV therapeutics over the next 5-10 years.

References

Jun 15, 1997·Annals of Internal Medicine·J W MellorsC R Rinaldo
Apr 15, 1999·Immunology Letters·B AutranP Debré
Mar 15, 2002·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Denise GravelGary Garber
Jul 12, 2002·Nature·Andreas JungAndreas Meyerhans
Jan 9, 2003·Proceedings of the National Academy of Sciences of the United States of America·Xiao-Feng QinDavid Baltimore
Jul 2, 2003·Nature Medicine·Mario Stevenson
May 29, 2004·Nature Genetics·Stephen J O'Brien, George W Nelson
Jan 19, 2006·The Journal of Experimental Medicine·William G GlassPhilip M Murphy
Jun 8, 2006·Annual Review of Biochemistry·Nigel D F GrindleyPhoebe A Rice
Jun 30, 2007·Science·Indrani SarkarFrank Buchholz
Jul 21, 2007·Science·Jacques FellayDavid B Goldstein
Aug 3, 2007·Proceedings of the National Academy of Sciences of the United States of America·Dong Sung AnIrvin S Y Chen
Sep 6, 2007·PLoS Pathogens·Ahmad R SedaghatRobert F Siliciano
Jan 9, 2008·The Journal of Infectious Diseases·Elin KindbergLennart Svensson
Feb 8, 2008·The New England Journal of Medicine·Simon MallalUNKNOWN PREDICT-1 Study Team
Jul 26, 2008·Science·Robert M GrantMark A Wainberg
Aug 5, 2008·JAMA : the Journal of the American Medical Association·Scott M HammerUNKNOWN International AIDS Society-USA
Sep 16, 2008·Antiviral Research·Warner C GreeneTomas Cihlar
Oct 4, 2008·Nature·Dan H Barouch
Nov 4, 2008·Cell Host & Microbe·Honglin ZhouAmy S Espeseth
Jan 7, 2009·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Lidia GazzolaGiulia Marchetti
Jan 20, 2009·Current HIV/AIDS Reports·Thomas GrambergNathaniel R Landau
Feb 14, 2009·The New England Journal of Medicine·Gero HütterEckhard Thiel
Feb 17, 2009·Nature Medicine·Ronald T MitsuyasuDavid A Cooper
Mar 7, 2009·Science·Douglas D RichmanRoger J Pomerantz
Apr 3, 2009·The New England Journal of Medicine·Mari M KitahataUNKNOWN NA-ACCORD Investigators

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Software Mentioned

Cre LoxP

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Related Papers

Current Opinion in Microbiology
M B Oldstone
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques
M Guttman, O Suchowersky
© 2021 Meta ULC. All rights reserved